Follow the people · Insider
Ronald M. Kurtz
Ronald M. Kurtz files insider transactions with the SEC as a chief medical officer of RxSight (RXST). We hold 1 disclosed purchase or sale filed since 2 August 2021, 1 of them in the last 90 days.
- Files forRXST
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure2 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 July 2021 — 2 September 2026Chief Medical Officer · RxSight (RXST)24 Form 4 lines · source: SEC Form 4
Everything they disclosed
24 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 13,425 shares of RxSightSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- ▼ sold on the open market 5,100 shares of RxSightSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- exercised options over 13,425 shares of RxSight (a derivative holding)SEC Form 42 September 2026Restricted Stock Unit · traded 31 August 2026 · filed 2 September 2026
- was granted 80,545 shares of RxSight (a derivative holding)SEC Form 43 March 2026Restricted Stock Unit · traded 27 February 2026 · filed 3 March 2026
- was granted 80,545 shares of RxSight (a derivative holding)SEC Form 43 March 2026Restricted Stock Unit · traded 27 February 2026 · filed 3 March 2026
- was granted 215,000 shares of RxSight (a derivative holding)SEC Form 427 February 2025Stock Option (right to buy) · traded 27 February 2025 · filed 27 February 2025
- exercised options over 7,650 shares of RxSight (a derivative holding)SEC Form 49 August 2024Stock Option (right to buy) · traded 9 August 2024 · filed 9 August 2024
- exercised options over 2,300 shares of RxSight (a derivative holding)SEC Form 49 August 2024Stock Option (right to buy) · traded 9 August 2024 · filed 9 August 2024
- exercised options over 7,650 shares of RxSightSEC Form 49 August 2024Common Stock · traded 9 August 2024 · filed 9 August 2024
- exercised options over 2,300 shares of RxSightSEC Form 49 August 2024Common Stock · traded 9 August 2024 · filed 9 August 2024
- exercised options over 13,500 shares of RxSight (a derivative holding)SEC Form 412 July 2024Stock Option (right to buy) · traded 11 July 2024 · filed 12 July 2024
- exercised options over 13,500 shares of RxSightSEC Form 412 July 2024Common Stock · traded 11 July 2024 · filed 12 July 2024
- ▼ sold on the open market 40,000 shares of RxSightSEC Form 46 May 2024Common Stock · traded 3 May 2024 · filed 6 May 2024
- was granted 149,000 shares of RxSight (a derivative holding)SEC Form 46 March 2024Stock Option (right to buy) · traded 4 March 2024 · filed 6 March 2024
- ▼ sold on the open market 31,250 shares of RxSightSEC Form 49 January 2024Common Stock · traded 8 January 2024 · filed 9 January 2024
- ▼ sold on the open market 31,250 shares of RxSightSEC Form 49 January 2024Common Stock · traded 8 January 2024 · filed 9 January 2024
- ▼ sold on the open market 22,500 shares of RxSightSEC Form 429 December 2023Common Stock · traded 27 December 2023 · filed 29 December 2023
- ▼ sold on the open market 20,000 shares of RxSightSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- ▼ sold on the open market 20,000 shares of RxSightSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- was granted 200,000 shares of RxSight (a derivative holding)SEC Form 410 March 2023Stock Option (right to buy) · traded 9 March 2023 · filed 10 March 2023
- was granted 40,000 shares of RxSightSEC Form 413 February 2023Common Stock · traded 10 February 2023 · filed 13 February 2023
- ▲ bought on the open market 125,000 shares of RxSightSEC Form 45 August 2021Common Stock · traded 3 August 2021 · filed 5 August 2021
- ▲ bought on the open market 3,638 shares of RxSightSEC Form 45 August 2021Common Stock · traded 5 August 2021 · filed 5 August 2021
- was granted 338,819 shares of RxSight (a derivative holding)SEC Form 42 August 2021Stock option (right to buy) · traded 31 July 2021 · filed 2 August 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.